IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
Phase 2 biotech developing antibiotics for antibiotic-resistant pathogens.
Industry: Health Care
Latest Trade: $2.02 0.00 (0.0%)
First Day Return: +31.5%
Return from IPO: -66.3%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 05/27/2021 |
Offer Price | $6.00 |
Price Range $5.00 - $7.00 | |
Offer Shares (mm) | 2.5 |
Deal Size ($mm) | $15 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 06/24/2021 |
Offer Price | $6.00 |
Price Range $5.00 - $7.00 | |
Offer Shares (mm) | 2.5 |
Deal Size ($mm) | $15 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
Alexander Capital |
Network 1 Financial Securities |
Company Data | |
---|---|
Headquarters | Staten Island, NY, United States |
Founded | 2017 |
Employees | 3 |
Website www.acurxpharma.com |